|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tyson GL and El-Serag HB: Risk factors for
cholangiocarcinoma. Hepatology. 54:173–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khan SA, Davidson BR, Goldin RD, Heaton N,
Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD,
Thillainayagam AV, et al: Guidelines for the diagnosis and
treatment of cholangiocarcinoma: An update. Gut. 61:1657–1669.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim SY, Yuzhalin AE, Gordon-Weeks AN and
Muschel RJ: Tumor-infiltrating monocytes/macrophages promote tumor
invasion and migration by upregulating S100A8 and S100A9 expression
in cancer cells. Oncogene. 35:5735–5745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu LX, Yan L, Yang W, Wu FQ, Ling Y, Chen
SZ, Tang L, Tan YX, Cao D, Wu MC, et al: Platelets promote tumour
metastasis via interaction between TLR4 and tumour cell-released
high-mobility group box1 protein. Nat Commun. 5:52562014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brantley-Sieders DM, Fang WB, Hwang Y,
Hicks D and Chen J: Ephrin-A1 facilitates mammary tumor metastasis
through an angiogenesis-dependent mechanism mediated by EphA
receptor and vascular endothelial growth factor in mice. Cancer
Res. 66:10315–10324. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalinsky K, Mayer JA, Xu X, Pham T, Wong
KL, Villarin E, Pircher TJ, Brown M, Maurer MA and Bischoff FZ:
Correlation of hormone receptor status between circulating tumor
cells, primary tumor, and metastasis in breast cancer patients.
Clin Transl Oncol. 17:539–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Srikrishna G: S100A8 and S100A9: New
insights into their roles in malignancy. J Innate Immun. 4:31–40.
2012. View Article : Google Scholar :
|
|
11
|
Leukert N, Vogl T, Strupat K, Reichelt R,
Sorg C and Roth J: Calcium-dependent tetramer formation of S100A8
and S100A9 is essential for biological activity. J Mol Biol.
359:961–972. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim SY, Raftery MJ and Geczy CL: Oxidative
modifications of DAMPs suppress inflammation: The case for S100A8
and S100A9. Antioxid Redox Signal. 15:2235–2248. 2011. View Article : Google Scholar
|
|
13
|
Porta C, Larghi P, Rimoldi M, Totaro MG,
Allavena P, Mantovani A and Sica A: Cellular and molecular pathways
linking inflammation and cancer. Immunobiology. 214:761–777. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hiratsuka S, Watanabe A, Sakurai Y,
Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S,
Aburatani H and Maru Y: The S100A8-serum amyloid A3-TLR4 paracrine
cascade establishes a pre-metastatic phase. Nat Cell Biol.
10:1349–1355. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kapanadze T, Gamrekelashvili J, Ma C, Chan
C, Zhao F, Hewitt S, Zender L, Kapoor V, Felsher DW, Manns MP, et
al: Regulation of accumulation and function of myeloid derived
suppressor cells in different murine models of hepatocellular
carcinoma. J Hepatol. 59:1007–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamerlik P, Lathia JD, Rasmussen R, Wu Q,
Bartkova J, Lee M, Moudry P, Bartek J Jr, Fischer W, Lukas J, et
al: Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma
stem-like cell viability and tumor growth. J Exp Med. 209:507–520.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chatterjee S, Heukamp LC, Siobal M,
Schöttle J, Wieczorek C, Peifer M, Frasca D, Koker M, König K,
Meder L, et al: Tumor VEGF:VEGFR2 autocrine feed-forward loop
triggers angiogenesis in lung cancer. J Clin Invest. 123:1732–1740.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alessi C, Scapulatempo Neto C, Viana CR
and Vazquez VL: PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph
node microenvironment and association with melanoma metastasis and
survival. Melanoma Res. 27:565–572. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang X, Zhang Y, Hosaka K, Andersson P,
Wang J, Tholander F, Cao Z, Morikawa H, Tegnér J, Yang Y, et al:
VEGF-B promotes cancer metastasis through a VEGF-A-independent
mechanism and serves as a marker of poor prognosis for cancer
patients. Proc Natl Acad Sci USA. 112:E2900–E2909. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gay LJ and Felding-Habermann B:
Contribution of platelets to tumour metastasis. Nat Rev Cancer.
11:123–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dehghani S, Nosrati R, Yousefi M, Nezami
A, Soltani F, Taghdisi SM, Abnous K, Alibolandi M and Ramezani M:
Aptamer-based biosensors and nanosensors for the detection of
vascular endothelial growth factor (VEGF): A review. Biosens
Bioelectron. 110:23–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang D, Song SJ, Wu ZZ, Wu W, Cui XY,
Chen JN, Zeng MS and Su SC: Epstein-barr virus-induced VEGF and
GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment
and activation of macrophages. Cancer Res. 77:3591–3604. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Ji S, Zhang B, Liu J, Qin Y, Xu J
and Yu X: Role of angiogenesis in pancreatic cancer biology and
therapy. Biomed Pharmacother. 108:1135–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Van Dreden P, Epsilonlalamy I and
Gerotziafas GT: The role of tissue factor in cancer-related
hypercoagulability, tumor growth, angiogenesis and metastasis and
future therapeutic strategies. Crit Rev Oncog. 22:219–248. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Long T, Liu Z, Shang J, Zhou X, Yu S, Tian
H and Bao Y: Polygonatum sibiricum polysaccharides play anti-cancer
effect through TLR4-MAPK/NF-κB signaling pathways. Int J Biol
Macromol. 111:813–821. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu JW, Young E, Busby B, Covington J and
Johnson JW: Oral administration of pyrrolidine dithiocarbamate
(PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of
breast cancer in female mice. Cancer Biol Ther. 8:514–521. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gan L, Pan S, Cui J, Bai J, Jiang P and He
Y: Functional analysis of the correlation between ABCB11 gene
mutation and primary intrahepatic stone. Mol Med Rep. 19:195–204.
2019.
|
|
28
|
Pan S, Li X, Jiang P, Jiang Y, Shuai L, He
Y and Li Z: Variations of ABCB4 and ABCB11 genes are associated
with primary intrahepatic stones. Mol Med Rep. 11:434–446. 2015.
View Article : Google Scholar
|
|
29
|
Zhang B, Wang D, Ji TF, Shi L and Yu JL:
Overexpression of lncRNA ANRIL up-regulates VEGF expression and
promotes angiogenesis of diabetes mellitus combined with cerebral
infarction by activating NF-κB signaling pathway in a rat model.
Oncotarget. 8:17347–17359. 2017.PubMed/NCBI
|
|
30
|
Labelle M and Hynes RO: The initial hours
of metastasis: The importance of cooperative host-tumor cell
interactions during hematogenous dissemination. Cancer Discov.
2:1091–1099. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shin JM, Park JH, Kim HJ, Park IH and Lee
HM: Cigarette smoke extract increases vascular endothelial growth
factor production via TLR4/ROS/MAPKs/NF-kappaB pathway in nasal
fibroblast. Am J Rhinol Allergy. 31:78–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Naruishi K and Nagata T: Biological
effects of interleukin-6 on Gingival Fibroblasts: Cytokine
regulation in periodontitis. J Cell Physiol. 233:6393–6400. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sonbare DJ: Influence of surgical margins
on outcome in patients with intrahepatic cholangiocarcinoma: A
multicenter study by the AFC-IHCC-2009 Study Group. Ann Surg.
259:e362014. View Article : Google Scholar
|
|
34
|
Lau SH and Lau WY: Current therapy of
hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 11:12–17.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yin DL, Liang YJ, Zheng TS, Song RP, Wang
JB, Sun BS, Pan SH, Qu LD, Liu JR, Jiang HC and Liu LX: EF24
inhibits tumor growth and metastasis via suppressing NF-kappaB
dependent pathways in human cholangiocarcinoma. Sci Rep.
6:321672016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ghavami S, Rashedi I, Dattilo BM, Eshraghi
M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C and Los M:
S100A8/A9 at low concentration promotes tumor cell growth via RAGE
ligation and MAP kinase-dependent pathway. J Leukoc Biol.
83:1484–1492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shabani F, Farasat A, Mahdavi M and Gheibi
N: Calprotectin (S100A8/S100A9): A key protein between inflammation
and cancer. Inflamm Res. 67:801–812. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Miller P, Kidwell KM, Thomas D, Sabel M,
Rae JM, Hayes DF, Hudson BI, El-Ashry D and Lippman ME: Elevated
S100A8 protein expression in breast cancer cells and breast tumor
stroma is prognostic of poor disease outcome. Breast Cancer Res
Treat. 166:85–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Steinckwich N, Schenten V, Melchior C,
Bréchard S and Tschirhart EJ: An essential role of STIM1, Orai1,
and S100A8-A9 proteins for Ca2+ signaling and FcgammaR-mediated
phagosomal oxidative activity. J Immunol. 186:2182–2191. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ieguchi K, Omori T, Komatsu A, Tomita T,
Deguchi A and Maru Y: Ephrin-A1 expression induced by S100A8 is
mediated by the toll-like receptor 4. Biochem Biophys Res Commun.
440:623–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tanriover G, Eyinc MB, Aliyev E, Dilmac S
and Erin N: Presence of S100A8/Gr1-positive myeloid-derived
suppressor cells in primary tumors and visceral organs invaded by
breast carcinoma cells. Clin Breast Cancer. 18:e1067–e1076. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Weis SM and Cheresh DA: Tumor
angiogenesis: Molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gacche RN and Meshram RJ: Angiogenic
factors as potential drug target: Efficacy and limitations of
anti-angiogenic therapy. Biochim Biophys Acta. 1846:161–179.
2014.PubMed/NCBI
|
|
44
|
Viallard C and Larrivée B: Tumor
angiogenesis and vascular normalization: Alternative therapeutic
targets. Angiogenesis. 20:409–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liang W and Ferrara N: The Complex role of
neutrophils in tumor angiogenesis and metastasis. Cancer Immunol
Res. 4:83–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li C, Li S, Jia C, Yang L, Song Z and Wang
Y: Low concentration of S100A8/9 promotes angiogenesis-related
activity of vascular endothelial cells: Bridges among inflammation,
angiogenesis, and tumorigenesis? Mediators Inflamm.
2012:2485742012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Viemann D, Strey A, Janning A, Jurk K,
Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, et al:
Myeloid-related proteins 8 and 14 induce a specific inflammatory
response in human microvascular endothelial cells. Blood.
105:2955–2962. 2005. View Article : Google Scholar
|
|
48
|
Viemann D, Barczyk K, Vogl T, Fischer U,
Sunderkötter C, Schulze-Osthoff K and Roth J: MRP8/MRP14 impairs
endothelial integrity and induces a caspase-dependent and
-independent cell death program. Blood. 109:2453–2460. 2007.
View Article : Google Scholar
|
|
49
|
Li Y, Xie G, Li L, Jiang Z, Yue Z and Pan
Z: The effect of TLR4/MyD88/NF-κB signaling pathway on
proliferation and apoptosis in human nasopharyngeal carcinoma 5-8F
cells induced by LPS. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za
Zhi. 29:1012–1015. 2015.In Chinese.
|
|
50
|
Jiang N, Xie F, Guo Q, Li MQ, Xiao J and
Sui L: Toll-like receptor 4 promotes proliferation and apoptosis
resistance in human papillomavirus-related cervical cancer cells
through the Toll-like receptor 4/nuclear factor-κB pathway. Tumour
Biol. 39:10104283177105862017. View Article : Google Scholar
|
|
51
|
O'Driscoll CM, Lima MP, Kaufmann WE and
Bressler JP: Methyl CpG binding protein 2 deficiency enhances
expression of inflammatory cytokines by sustaining NF-κB signaling
in myeloid derived cells. J Neuroimmunol. 283:23–29. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Low P, Clark AM, Chou TC, Chang TC,
Reynolds M and Ralph SJ: Immunomodulatory activity of Melaleuca
alternifolia concentrate (MAC): Inhibition of LPS-induced NF-κB
activation and cytokine production in myeloid cell lines. Int
Immunopharmacol. 26:257–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
